←back to thread

FAQ on Leaving Google

(social.clawhammer.net)
462 points mrled | 2 comments | | HN request time: 0.414s | source
Show context
thrtythreeforty ◴[] No.39035233[source]
The author also published [1] an email he wrote at the beginning of his tenure. It is amazing how alien and out of place early Google sounds in today's corporate environment. They have completely eroded the perception that Google is this kind of place:

> Google is the opposite: it's like a giant grad-school. Half the programmers have PhD's, and everyone treats the place like a giant research playground [...] Every once in a while, a manager skims over the bubbling activity, looking for products to "reap" from the creative harvest. The programmers completely drive the company, it's really amazing. I kept waiting for people to walk up to me and ask me if I had declared my major yet. They not only encourage personal experimentation and innovation, they demand it. Every programmer is required to spend 20% of their time working on random personal projects. If you get overloaded by a crisis, then that 20% personal time accrues anyway. Nearly every Google technology you know (maps, earth, gmail) started out as somebody's 20% project, I think.

Even if this was only half-true back then, there's very little you could do to convince me that it's true at all now. This culture and the public perception of it has been squandered.

[1]: https://social.clawhammer.net/blog/posts/2005-09-25-FirstWee...

replies(6): >>39035428 #>>39035523 #>>39035569 #>>39035617 #>>39035738 #>>39046460 #
dekhn ◴[] No.39035428[source]
That was an absolutely spot-on description of what it was like when I joined in 2007 or 2008. Within 2 year of joining, I had approval to use all the idle cycles in prod for protein design, folding, and drug discovery, and I had a front-row seat with some of the best programmers in the industry. By and large, employees were fun people to interact with, and the management was generally understanding of our hijinx. The main struggle I had was to convince the leadership to move faster into the cloud ("But we have appengine!" and "But profits aren't as good as ads", until MSFT ate their lunch). As soon as it was possible, I built and launched the cloud product I had wanted Google to make even before I joined!

It really did just feel like grad school with better funding. For me it lasted until around 2014 (wow, 10 years ago) when a director stole my ideas and bad-mouthed me to a bunch of senior folks. I hung on a bit longer (working for a close friend of the author of this FAQ on 3d printing and making stuff) and then a couple stints with ML hardware, before I finally concluded that the company was well on its way to enhittifying everything it did.

Sundar is sort of the complete opposite of this. He wants a large pool of completely anonymous programmers and a small number of directors who know how to turn those programmers into growth products, but those directors don't have a clue. For example, with gChat, one day the head of chat told TGIF that chat was changing, that japanese teen girls were the primary target, and they wanted emojis. He didn't even get that there was this enormous number of professional workers using gmail/gchat/gcal/gdocs and that by fucking up the product, he lost their trust.

Oh well. Sundar is why we can't have nice things.

replies(8): >>39035473 #>>39035618 #>>39035687 #>>39036936 #>>39037783 #>>39037889 #>>39043334 #>>39044029 #
heyoni ◴[] No.39036936[source]
Jesus. Tell me more. You didn’t happen to be involved in deepmind are you? I kind of _loathe_ google these days but find it absolutely mind blowing that there was a time when they were just casually unblocking the scientific community for funsies…to the point where parents could just leverage google’s freebies to maybe shed some light on their kids’ rare disease.

It pains me to think this won’t be happening anymore because really, you can’t sic your brightness engineers on detecting ad blockers _and_ casually make scientific breakthroughs. Something happened to google and the we’ll be writing about for decades to come but if there’s one thing I’m certain it’s that they are done trying to make the world a better place.

replies(2): >>39037650 #>>39042424 #
mike_hearn ◴[] No.39042424[source]
Has that changed? AlphaFold is recent and was practically given away to the biotech community. Google is doing a startup based around it as well. So they're still unblocking scientists for funsies, maybe moreso than in the past.
replies(2): >>39044681 #>>39050936 #
1. dekhn ◴[] No.39044681[source]
Google/Deepmind research still has a fairly large subgroup working on health problems, but most of that work is not given away (or even easily licensable) or published in a way that competitors could reproduce.

What Isomorphic, the spinoff, learned pretty quickly is that protein structure prediction is not, has never been, and is unlikely to be, the most critical blocking step in developing new drugs. That won't stop pharma from investing biobucks (virtual dollars that are gated by milestones) in them. Right now pharma is terrified because their pipelines are drying up, their blockbusters are going generic, and the recent rates of new discoveries leading to new candidates (target diseases/bio pathways) are dropping, even as they invest more and more into automation and machine learning.

(By the way Mike- I always did wish you had been able to run your "math problems" on exacycle, as a way of monetizing idle cores)

replies(1): >>39053532 #
2. mike_hearn ◴[] No.39053532[source]
Ahhh, I wondered about the importance of structure prediction for a long time, ever since reading those blog posts by a PSP researcher in academia who was complaining that big pharma didn't invest in the field. He was asking "why was it Google who solved this problem and not a Pfizer or Bayer?" His posited explanation was a sort of cultural/institutional disinterest in advanced R&D, but that didn't sound very plausible compared to the other possibility that they just didn't care much about the problem to begin with.

> That won't stop pharma from investing biobucks (virtual dollars that are gated by milestones) in them.

I didn't quite follow this, could you maybe elaborate? What is a virtual dollar in this context? Do you mean they make promises of future payments if certain goals are achieved, but the dollars never become real because the goals aren't achievable?

Re: math problems. I remember looking at Exacycle and wondering about that :) but concluded it would have been self defeating, as it'd just have resulted in Google dominating the network and that'd have been seen as an attack.